Pharmx Technologies Ltd (PHX) - Cash Flow Conversion Efficiency

Latest as of December 2024: -0.552x

Based on the latest financial reports, Pharmx Technologies Ltd (PHX) has a cash flow conversion efficiency ratio of -0.552x as of December 2024. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (AU$-8.91 Million ≈ $-6.30 Million USD) by net assets (AU$16.15 Million ≈ $11.43 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Check Pharmx Technologies Ltd strategic capital allocation to assess the company's strategic physical and investment asset allocation.

Pharmx Technologies Ltd - Cash Flow Conversion Efficiency Trend (2007–2024)

This chart illustrates how Pharmx Technologies Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. See Pharmx Technologies Ltd shareholders equity for net asset value and shareholders' equity analysis.

Pharmx Technologies Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Pharmx Technologies Ltd ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
American Tungsten & Antimony Ltd AU:AT4	-0.417x
Articore Group Ltd AU:ATG	-1.004x
Instil Bio Inc. NASDAQ:TIL	-0.062x
Aplisens SA WAR:APN	0.047x
Akin Tekstil AS IS:ATEKS	0.001x
Inmax Holding Co Ltd TWO:1591	-0.044x
BP Plastics Holding Bhd KLSE:5100	0.020x
Broad Capital Acquisition Corp NASDAQ:BRAC	0.008x

Annual Cash Flow Conversion Efficiency for Pharmx Technologies Ltd (2007–2024)

The table below shows the annual cash flow conversion efficiency of Pharmx Technologies Ltd from 2007 to 2024. For the full company profile with market capitalisation and key ratios, see PHX company net worth.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2024-06-30	AU$15.97 Million ≈ $11.30 Million	AU$3.21 Million ≈ $2.27 Million	0.201x	-59.28%
2023-06-30	AU$22.21 Million ≈ $15.72 Million	AU$10.94 Million ≈ $7.74 Million	0.493x	+421.33%
2022-06-30	AU$23.20 Million ≈ $16.42 Million	AU$2.19 Million ≈ $1.55 Million	0.095x	-31.46%
2021-06-30	AU$22.93 Million ≈ $16.22 Million	AU$3.16 Million ≈ $2.24 Million	0.138x	+393.18%
2020-06-30	AU$13.20 Million ≈ $9.34 Million	AU$369.00K ≈ $261.09K	0.028x	-79.21%
2019-06-30	AU$10.02 Million ≈ $7.09 Million	AU$1.35 Million ≈ $953.80K	0.135x	+476.38%
2018-06-30	AU$14.23 Million ≈ $10.07 Million	AU$332.00K ≈ $234.91K	0.023x	+30.98%
2017-06-30	AU$13.98 Million ≈ $9.89 Million	AU$249.00K ≈ $176.18K	0.018x	+127.93%
2016-06-30	AU$19.91 Million ≈ $14.09 Million	AU$-1.27 Million ≈ $-898.61K	-0.064x	-135.99%
2015-06-30	AU$19.93 Million ≈ $14.10 Million	AU$3.53 Million ≈ $2.50 Million	0.177x	-41.07%
2014-06-30	AU$18.87 Million ≈ $13.35 Million	AU$5.68 Million ≈ $4.02 Million	0.301x	-25.59%
2013-06-30	AU$16.36 Million ≈ $11.57 Million	AU$6.61 Million ≈ $4.68 Million	0.404x	-7.53%
2012-06-30	AU$10.68 Million ≈ $7.55 Million	AU$4.67 Million ≈ $3.30 Million	0.437x	-44.72%
2011-06-30	AU$4.65 Million ≈ $3.29 Million	AU$3.67 Million ≈ $2.60 Million	0.791x	+1.31%
2010-06-30	AU$2.90 Million ≈ $2.05 Million	AU$2.26 Million ≈ $1.60 Million	0.780x	-10.54%
2008-06-30	AU$5.11 Million ≈ $3.61 Million	AU$4.46 Million ≈ $3.15 Million	0.872x	+148.45%
2007-06-30	AU$7.55 Million ≈ $5.34 Million	AU$2.65 Million ≈ $1.88 Million	0.351x	--

About Pharmx Technologies Ltd

AU:PHX Australia Health Information Services

Market Cap

$55.14 Million

AU$77.94 Million AUD

Market Cap Rank

#21619 Global

#772 in Australia

Share Price

AU$0.13

Change (1 day)

+13.04%

52-Week Range

AU$0.08 - AU$0.17

All Time High

AU$0.17